Lab
Jose Carlos Flores Santiago
Jose Carlos Flores Santiago was paid $9.64M by Medicaid between Jan 2018 and Dec 2024, across 127 billing codes. Its largest line is 84443, Thyroid stimulating hormone (TSH) — 11% of everything it billed.
33Billing provider infoJOSE CARLOS FLORES SANTIAGO
JUNCOS, PR 00777
JUNCOS, PR 00777
33aNPI1124060843assigned 06/11/2006
33bProvider typeClinical Medical Laboratory
28Total paid$9.64M
24GClaims736,738
24DCodes billed127
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#9 of 777
Median peer was paid$278K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70,567 | $608K | |
| 2019 | 78,283 | $669K | |
| 2020 | 92,882 | $1.21M | |
| 2021 | 115,753 | $2.03M | |
| 2022 | 102,852 | $1.66M | |
| 2023 | 107,493 | $1.37M | |
| 2024incomplete | 168,908 | $2.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 84443 | Thyroid stimulating hormone (TSH) | 11% | 56,816 | 49,376 | $1.01M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 10% | 22,521 | 19,420 | $971K |
| 80061 | Lipid panel | 8.9% | 59,142 | 51,561 | $854K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8.3% | 15,906 | 14,617 | $804K |
| 80053 | Comprehensive metabolic panel | 7.6% | 64,051 | 55,107 | $731K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.1% | 27,919 | 25,346 | $681K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.7% | 92,606 | 77,449 | $647K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.6% | 16,635 | 14,540 | $447K |
| 83036 | Hemoglobin; glycosylated (A1C) | 4.0% | 37,909 | 33,005 | $387K |
| 81000 | 2.5% | 69,699 | 59,985 | $237K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.8% | 5,382 | 4,542 | $178K |
| 86738 | 1.8% | 13,753 | 11,614 | $172K |
115 more codes
| 87276 | 1.8% | 14,954 | $171K | |
| 80074 | 1.7% | 3,571 | $160K | |
| 82274 | 1.7% | 11,263 | $160K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.7% | 4,800 | $159K |
| 87275 | 1.6% | 14,935 | $156K | |
| 82043 | 1.3% | 23,389 | $122K | |
| 84153 | 1.2% | 6,886 | $114K | |
| 84439 | 1.1% | 12,884 | $107K | |
| 87088 | 1.0% | 10,965 | $97K | |
| 86701 | 1.0% | 11,785 | $97K | |
| 82607 | <1% | 5,873 | $81K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,465 | $76K |
| 86328 | <1% | 3,216 | $61K | |
| 84436 | <1% | 8,132 | $51K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 935 | $48K |
| 84479 | <1% | 7,972 | $46K | |
| 86769 | <1% | 930 | $37K | |
| 86803 | <1% | 2,728 | $37K | |
| 82570 | <1% | 7,654 | $36K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,570 | $34K |
| 86592 | <1% | 8,447 | $33K | |
| 86696 | <1% | 1,799 | $32K | |
| 83001 | <1% | 1,804 | $31K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 5,667 | $29K |
| 86038 | <1% | 2,544 | $28K | |
| 85730 | <1% | 4,996 | $27K | |
| 87899 | <1% | 1,554 | $23K | |
| 84146 | <1% | 1,199 | $21K | |
| 83002 | <1% | 1,241 | $21K | |
| 82728 | <1% | 1,469 | $19K | |
| 85610 | <1% | 5,162 | $18K | |
| 85651 | <1% | 5,514 | $18K | |
| 82951 | <1% | 1,430 | $17K | |
| 82746 | <1% | 1,141 | $15K | |
| 83970 | <1% | 402 | $15K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,298 | $15K |
| 84703 | <1% | 2,347 | $14K | |
| 84550 | <1% | 3,089 | $12K | |
| 87177 | <1% | 2,218 | $12K | |
| 86140 | <1% | 2,482 | $11K | |
| 82950 | <1% | 2,568 | $11K | |
| 84702 | <1% | 943 | $11K | |
| 86694 | <1% | 839 | $11K | |
| 83655 | <1% | 953 | $11K | |
| 86695 | <1% | 812 | $11K | |
| 82670 | <1% | 387 | $10K | |
| 84403 | <1% | 411 | $10K | |
| 82105 | <1% | 632 | $9K | |
| 85027 | <1% | 1,799 | $9K | |
| 80069 | <1% | 1,178 | $9K | |
| 86430 | <1% | 1,544 | $8K | |
| 82947 | <1% | 2,213 | $8K | |
| 83550 | <1% | 928 | $7K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 92 | $6K |
| 86762 | <1% | 468 | $6K | |
| 84160 | <1% | 1,248 | $6K | |
| 82952 | <1% | 926 | $6K | |
| 87340 | <1% | 549 | $5K | |
| 83540 | <1% | 862 | $5K | |
| 84481 | <1% | 321 | $5K | |
| 86376 | <1% | 377 | $5K | |
| 82677 | <1% | 213 | $5K | |
| 86900 | <1% | 1,465 | $4K | |
| 86901 | <1% | 1,442 | $4K | |
| 86800 | <1% | 285 | $4K | |
| 87084 | <1% | 153 | $4K | |
| 87490 | <1% | 199 | $4K | |
| 87590 | <1% | 198 | $4K | |
| 82565 | <1% | 744 | $3K | |
| 86886 | <1% | 699 | $3K | |
| 84460 | <1% | 682 | $3K | |
| 84450 | <1% | 691 | $3K | |
| 87070 | <1% | 398 | $3K | |
| 86703 | <1% | 236 | $3K | |
| 83880 | <1% | 72 | $3K | |
| 84156 | <1% | 825 | $3K | |
| 83690 | <1% | 411 | $2K | |
| 82378 | <1% | 128 | $2K | |
| 86677 | <1% | 175 | $2K | |
| 85660 | <1% | 432 | $2K | |
| 82150 | <1% | 353 | $2K | |
| 80076 | <1% | 277 | $2K | |
| 86160 | <1% | 81 | $2K | |
| 82575 | <1% | 204 | $2K | |
| 84480 | <1% | 122 | $2K | |
| 84520 | <1% | 420 | $2K | |
| 80050 | General health panel | <1% | 150 | $1K |
| 86336 | <1% | 93 | $1K | |
| 86141 | <1% | 70 | $781.92 | |
| 84402 | <1% | 30 | $770.94 | |
| 0004A | <1% | 56 | $680.00 | |
| 86304 | <1% | 36 | $677.94 | |
| 82785 | <1% | 41 | $644.64 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 96 | $571.24 |
| 86235 | <1% | 12 | $569.18 | |
| 83525 | <1% | 43 | $534.35 | |
| 83615 | <1% | 92 | $515.46 | |
| 86787 | <1% | 38 | $478.38 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 599 | $406.32 |
| 83735 | <1% | 55 | $346.74 | |
| 84154 | <1% | 16 | $289.87 | |
| 84144 | <1% | 15 | $277.90 | |
| 84100 | <1% | 68 | $276.91 | |
| 82672 | <1% | 13 | $248.28 | |
| 86225 | <1% | 18 | $236.75 | |
| 86317 | <1% | 12 | $202.08 | |
| 87338 | <1% | 13 | $152.77 | |
| 86200 | <1% | 12 | $148.08 | |
| 82248 | <1% | 29 | $137.33 | |
| 82270 | <1% | 49 | $130.72 | |
| 84478 | <1% | 16 | $84.30 | |
| 82977 | <1% | 14 | $79.41 | |
| 82465 | <1% | 18 | $71.31 | |
| 85018 | <1% | 16 | $30.23 | |
| 0003A | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBELTRAI, MYRNA (VICE PRESIDENT)